213 related articles for article (PubMed ID: 19852529)
1. Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer.
Baldwin CM; Perry CM
Drugs; 2009 Nov; 69(16):2279-302. PubMed ID: 19852529
[TBL] [Abstract][Full Text] [Related]
2. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II study.
Karayama M; Inui N; Kuroishi S; Yokomura K; Toyoshima M; Shirai T; Masuda M; Yamada T; Yasuda K; Suda T; Chida K
Cancer Chemother Pharmacol; 2013 Aug; 72(2):445-52. PubMed ID: 23807323
[TBL] [Abstract][Full Text] [Related]
4. Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer.
Cohen MH; Justice R; Pazdur R
Oncologist; 2009 Sep; 14(9):930-5. PubMed ID: 19737998
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer.
Xu B; Liu P; Yin Y; Liu P; Shu Y
Biomed Pharmacother; 2013 Oct; 67(8):763-9. PubMed ID: 23790249
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed disodium for the treatment of NSCLC: an update.
Hsu JY; Wakelee H
Drugs Today (Barc); 2008 Sep; 44(9):669-78. PubMed ID: 19137122
[TBL] [Abstract][Full Text] [Related]
7. ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.
Smit EF; Mattson K; von Pawel J; Manegold C; Clarke S; Postmus PE
Ann Oncol; 2003 Mar; 14(3):455-60. PubMed ID: 12598353
[TBL] [Abstract][Full Text] [Related]
8. [Clinical investigation of efficacy of third-line and beyond pemetrexed treatment in advanced non-squamous non-small cell lung cancer].
Yu F; Liu X; Li X; Li J; Guo W; Qin H; Gao H
Zhongguo Fei Ai Za Zhi; 2012 Feb; 15(2):117-21. PubMed ID: 22336241
[TBL] [Abstract][Full Text] [Related]
9. [Pemetrexed combined with cisplatin or carboplatin regimen in the treatment of advanced recurrent or metastasis non-small cell lung cancer: analysis of 63 cases].
Wang W; Shang L; Li X; Li J; Wen F; Liu J
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):54-7. PubMed ID: 21219833
[TBL] [Abstract][Full Text] [Related]
10. Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study.
Sun Y; Wu YL; Zhou CC; Zhang L; Zhang L; Liu XY; Yu SY; Jiang GL; Li K; Qin SK; Ma SL; Han L; Quinlivan M; Orlando M; Zhang XQ
Lung Cancer; 2013 Feb; 79(2):143-50. PubMed ID: 23182660
[TBL] [Abstract][Full Text] [Related]
11. The role of pemetrexed in second-line chemotherapy for advanced non-small cell lung cancer.
Tucker S
Curr Drug Targets; 2010 Jan; 11(1):58-60. PubMed ID: 19839927
[TBL] [Abstract][Full Text] [Related]
12. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed in advanced non-small-cell lung cancer.
Fuld AD; Dragnev KH; Rigas JR
Expert Opin Pharmacother; 2010 Jun; 11(8):1387-402. PubMed ID: 20446853
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.
Kim YH; Hirabayashi M; Kosaka S; Nikaidoh J; Yamamoto Y; Shimada M; Toyazaki T; Nagai H; Sakamori Y; Mishima M
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1445-51. PubMed ID: 23532206
[TBL] [Abstract][Full Text] [Related]
15. Pemetrexed in advanced non-small cell lung cancer.
Gridelli C; Maione P; Rossi A; Bareschino MA; Schettino C; Sacco PC; Zeppa R
Expert Opin Drug Saf; 2011 Mar; 10(2):311-7. PubMed ID: 21261558
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.
Greenhalgh J; McLeod C; Bagust A; Boland A; Fleeman N; Dundar Y; Oyee J; Dickson R; Davis H; Green J; McKenna E; Pearson M
Health Technol Assess; 2010 Oct; 14(Suppl. 2):33-9. PubMed ID: 21047489
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.
Shepherd FA; Dancey J; Arnold A; Neville A; Rusthoven J; Johnson RD; Fisher B; Eisenhauer E
Cancer; 2001 Aug; 92(3):595-600. PubMed ID: 11505404
[TBL] [Abstract][Full Text] [Related]
18. [Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].
de Marinis F; Ricciardi S
Tumori; 2008; 94(5):suppl 3-13. PubMed ID: 19112963
[No Abstract] [Full Text] [Related]
19. Pemetrexed in the treatment of advanced non-squamous lung cancer.
Rossi A; Ricciardi S; Maione P; de Marinis F; Gridelli C
Lung Cancer; 2009 Nov; 66(2):141-9. PubMed ID: 19577816
[TBL] [Abstract][Full Text] [Related]
20. [A randomized clinical study of Gefitinib and pemetrexed as second line therapy for advanced non-squamous non-small cell lung cancer].
Dai H; Xu L; Xia C; Chen W
Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):405-10. PubMed ID: 23945243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
